Clinical Trial Update: Penumbral Based Novel Thrombolytic Therapy in Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a penumbral-based novel thrombolytic therapy for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Infarction
• Stroke

Drugs mentioned

• Penumbral Based Novel Thrombolytic Therapy

Snippet

Sponsor: University of Alberta | Conditions: Cerebral Infarction, Brain Ischemia | Phase 2 | Status: COMPLETED